Natalio Krasnogor and his team at Newcastle University were staring at a problem that had quietly plagued DNA origami for years: even when scientists designed perfect blueprints, the nanostructures often misfolded, like a high-precision machine built from parts that didn’t quite fit. These tiny DNA shapes—engineered from a long scaffold strand and dozens of short staples—hold immense promise for delivering drugs inside the body or building nanoscale biosensors. But their reliability has been inconsistent, and the reason, it turns out, lies hidden in the very sequence of DNA letters.
Now, in a breakthrough published in Nature Communications, Krasnogor’s international team has unveiled a computational tool that dramatically improves the odds of successful folding by predicting and eliminating off-target interactions between DNA strands. These unintended bindings, which can derail the self-assembly process, are now avoidable thanks to an algorithm that selects optimal scaffold sequences—whether from natural sources like the M13 bacteriophage or synthetic alternatives. The result is not just more accurate folding, but nanostructures with greater mechanical uniformity, a must for real-world applications.
The team tested their Sequence Selector tool on both 2D and 3D DNA origami, including triangular and barrel-shaped designs. In every case, sequences flagged as low-risk for off-target interactions achieved significantly higher folding yields. One experiment showed that a poorly chosen scaffold led to near-total assembly failure, despite a flawless structural design—proof that sequence matters as much as shape. Researchers from institutions including the University of Bordeaux, Università degli Studi di Udine, Israel Institute of Technology, and Universität Bonn contributed experimental validation using agarose gel electrophoresis and atomic force microscopy (AFM), confirming that optimized sequences produced cleaner, more consistent results.
The implications extend far beyond the lab bench. In medicine, reliable DNA origami could mean programmable nanocarriers that deliver mRNA or cancer drugs directly to cells. In agritech, they might be used to protect crops at the molecular level. "We provide a novel software able to select optimal DNA sequences for a given target origami nanostructure shape," says Professor Emanuela Torelli, a key contributor from Udine and Newcastle. The tool is already being integrated into ongoing research, with Professor Michael Famulok at Universität Bonn reporting reduced misfolding in his team’s designs since adopting the algorithm.
This isn’t just refinement—it’s a rethinking of DNA origami as a truly programmable technology. By treating the DNA sequence not as a passive template but as an active participant in folding success, the team has opened a new frontier in nanoscale engineering. As the tools evolve, so does the dream: of tiny, self-assembling machines built with the precision of code and the elegance of life’s own blueprint.